Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MORRIS PLAINS, N.J., May 29, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases,today announced that the Company will present at Jefferies 2013 Global Healthcare Conference at 2:30 p.m. Eastern Time on Thursday, June 6, 2013, in New York City. The presentation, which will provide a corporate overview, can be downloaded simultaneously at www.immunomedics.com/pdfs/company-presentation.pdf.
Help employers find you! Check out all the jobs and post your resume.
MORRIS PLAINS, N.J., May 29, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases,today announced that the Company will present at Jefferies 2013 Global Healthcare Conference at 2:30 p.m. Eastern Time on Thursday, June 6, 2013, in New York City. The presentation, which will provide a corporate overview, can be downloaded simultaneously at www.immunomedics.com/pdfs/company-presentation.pdf.
Help employers find you! Check out all the jobs and post your resume.
